SCHEMBL26833512

SCHEMBL26833512

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7cnc8ccncc8c7)cc6)c6ccc(-c7cnc8ccncc8c7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 4/20 0.50
▸ PDGFRA P16234 4/20 0.50
▸ PIK3CD O00329 2/20 0.49
▸ PIK3CA P42336 2/20 0.49
▸ CYP2A6 P11509 1/20 0.45
▸ MAPK10 P53779 5/20 0.42
▸ CYP17A1 P05093 1/20 0.42
▸ CYP19A1 P11511 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ AKT1 P31749 2/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ BIRC5 O15392 1/20 0.39
▸ PRKCZ Q05513 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833521 0.92 PDGFRB (0.48) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833448 0.90 PDGFRB (0.50) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833454 0.88 CYP17A1 (0.48) PDGFRBPDGFRAPIK3CDMAPK10CYP17A1
SCHEMBL26833455 0.88 PRKCZ (0.50) PDGFRBPDGFRAPIK3CDMAPK10CYP17A1
SCHEMBL26833451 0.87 NPC1 (0.50) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833666 0.86 CYP19A1 (0.40) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833508 0.86 PIK3CD (0.58) PDGFRBPDGFRAPIK3CDPIK3CAMAPK10
SCHEMBL26834052 0.85 PIK3CD (0.52) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26833663 0.84 MAPK10 (0.43) PDGFRBPDGFRAPIK3CDPIK3CACYP2A6
SCHEMBL26834054 0.83 CYP11B1 (0.44) MAPK10CYP17A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 PDGFRB 1812/4885PDGFRA 1655/4885PIK3CD 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback